Ezio Bonvini

Senior Vice President, Research & Chief Scientific Officer at MacroGenics, Inc.

Ezio Bonvini

Ezio Bonvini

Senior Vice President, Research & Chief Scientific Officer at MacroGenics, Inc.

Overview
RelSci Relationships

2036

Birthday

1954

Age

67

Relationships
RelSci Relationships are individuals Ezio Bonvini likely has professional access to. A relationship does not necessarily indicate a personal connection.

Co-Founder at MacroGenics, Inc.

Relationship likelihood: Strong

Former Senior Vice President-Product Development & Regulatory Affairs at MacroGenics, Inc.

Relationship likelihood: Strong

Chief Biotechnology Officer at Janssen Research & Development LLC

Relationship likelihood: Strong

Senior Vice President, Chief Financial Officer & Secretary at MacroGenics, Inc.

Relationship likelihood: Strong

General Counsel at MacroGenics, Inc.

Relationship likelihood: Strong

Acting Associate Commissioner for Special Medical Programs at U.S. Food and Drug Administration

Relationship likelihood: Strong

Vice President, Controller & Treasurer at MacroGenics, Inc.

Relationship likelihood: Strong

Senior Director of Business Development at MacroGenics, Inc.

Relationship likelihood: Strong

Director of the Center for Drug Evaluation & Research at U.S. Food and Drug Administration

Relationship likelihood: Strong

Vice President, Clinical Development & Medical Affairs at MaxCyte, Inc.

Relationship likelihood: Strong

Paths to Ezio Bonvini
Potential Connections via
Relationship Science
You
Ezio Bonvini
Senior Vice President, Research & Chief Scientific Officer at MacroGenics, Inc.
Education
MD Clinical Hematology

The University of Genoa is one of the most valuable cultural and scientific heritage of the Mediterranean and the Italian north-western area. It is deeply interconnected with the city of Genoa and its economic framework. The University is located throughout the region, with campuses also in Savona, Imperia and La Spezia.

Career History
Senior Vice President, Research & Chief Scientific Officer
2003 - Current

MacroGenics is a leader in the discovery and development of innovative medicinces that utilize our next generation antibody-based technologies. Our team of 150+ dedicated individuals is advancing a pipeline of product candidates to treat patients with cancer and other serious, complex diseases. Our products and platforms have attracted multiple partnerships with leading pharmaceutical companies around the globe. Our innovative product candidates leverage our fully-integrated capabilities around the discovery, development, and production of antibodies and incorporate three proprietary technology platforms: Our Dual-Affinity Re-Targeting (DART™) platform enables us to design candidate therapeutics that target multiple disease-causing cells or redundant disease-associated pathways with a single molecule; Our Fc Optimization platform enhances the natural immune system's ability to mediate killing of cancer cells; and Our Cancer Stem Cell platform provides new approaches to target cancers unresponsive to current therapy.

Acting Deputy Director, Division of Monoclonal Antibodies & Chief, Laboratory of Immunobiology
1985 - 2003

The Food and Drug Administration (FDA or USFDA) is an agency of the United States Department of Health and Human Services, one of the United States federal executive departments. The FDA is responsible for protecting and promoting public health through the regulation and supervision of food safety, tobacco products, dietary supplements, prescription and over-the-counter pharmaceutical drugs (medications), vaccines, biopharmaceuticals, blood transfusions, medical devices, electromagnetic radiation emitting devices (ERED), and veterinary products. The FDA also enforces other laws, notably Section 361 of the Public Health Service Act and associated regulations, many of which are not directly related to food or drugs. These include sanitation requirements on interstate travel and control of disease on products ranging from certain household pets to sperm donation for assisted reproduction. The FDA is led by the Commissioner of Food and Drugs, appointed by the President with the advice and consent of the Senate. The Commissioner reports to the Secretary of Health and Human Services. The 21st and current Commissioner is Dr. Margaret A. Hamburg. She has served as Commissioner since May 2009. The FDA has its headquarters in unincorporated White Oak, Maryland. The agency also has 223 field offices and 13 laboratories located throughout the 50 states, the United States Virgin Islands, and Puerto Rico. In 2008, the FDA started opening offices in foreign countries, including China, India, Costa Rica, Chile, Belgium, and the United Kingdom. In June 1906, President Theodore Roosevelt signed into law the Food and Drug Act, also known as the "Wiley Act" after its chief advocate Dr. Harvey Washington Wiley who riveted the country's and eventually congress's attention with public hygiene demonstrations. This act was the basis for the modern USFDA, being originally given the name of the Food, Drug, and Insecticide organization. The name eventually was shortened to the Food and Drug Administration (FDA) a few years later.

Director-Deputy Division
1985 - 2003

Center for Biologics Evaluation & Research engages in the regulation of biological and related products. Its scope includes blood, vaccines, allergenics, tissues, and cellular and gene therapies. The company is headquartered in Silver Spring, MD.

Non-Profit Donations & Grants

Learn how non-profit organizations benefit from RelSci
$1 - $249
2017

The American Society of Hematology 's mission is to further the understanding, diagnosis, treatment, and prevention of disorders affecting the blood, bone marrow, and the immunologic, hemostatic and vascular systems, by promoting research, clinical care, education, training, and advocacy in hematology.

$10 - $99
2017

Keystone Symposia operates as a catalyst for the advancement of biomedical and life sciences by connecting scientists within and across disciplines at conferences and workshops. The company was founded by C. Fred Fox in 1972 and is headquartered in Silverthorne, CO.

$150 - $249
2016

The American Association of Immunologists is an association of professionally trained scientists from all over the world dedicated to advancing the knowledge of immunology and its related disciplines, fostering the interchange of ideas and information among investigators, and addressing the potential integration of immunologic principles into clinical practice. The American Association of Immunologists serves its members by providing a center for the dissemination of information relevant to the field and its practices, such as educational and professional opportunities, scientific meetings, membership-derived issues and opinions, and important social and political issues. AAI owns and publishes The Journal of Immunology—the largest and most highly cited journal in the field.

Public Holdings
Restricted data only for RelSci Professional users.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Ezio Bonvini. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Ezio Bonvini's profile does not indicate a business or promotional relationship of any kind between RelSci and Ezio Bonvini.